Shenzhen Lifotronic Technology Co Market Cap ($731.09 Million)
Market Cap & Net Worth: Shenzhen Lifotronic Technology Co (688389)
Shenzhen Lifotronic Technology Co market cap. Shenzhen Lifotronic Technology Co (SHG:688389) has a market capitalization of $731.09 Million (CN¥5.00 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #9979 globally and #2598 in its home market, demonstrating a -2.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenzhen Lifotronic Technology Co's stock price CN¥11.66 by its total outstanding shares 428485730 (428.49 Million). Also see 688389 operating cash flow for how efficiently the company converts equity into cash flow.
Shenzhen Lifotronic Technology Co Market Cap History (2019–2026)
Shenzhen Lifotronic Technology Co market cap history from 2019 to 2026. Data shows change from $995.99 Million to $731.09 Million (-6.72% CAGR). Check current stock price of Shenzhen Lifotronic Technology Co for real-time trading data and today's change.
Shenzhen Lifotronic Technology Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenzhen Lifotronic Technology Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 688389 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.78x
Shenzhen Lifotronic Technology Co's market cap is 0.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.37x
Shenzhen Lifotronic Technology Co's market cap is 4.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $995.99 Million | $422.64 Million | $100.56 Million | 2.36x | 9.90x |
| 2020 | $1.28 Billion | $553.82 Million | $143.95 Million | 2.31x | 8.89x |
| 2021 | $1.41 Billion | $778.11 Million | $190.35 Million | 1.81x | 7.42x |
| 2022 | $1.11 Billion | $983.04 Million | $251.48 Million | 1.13x | 4.40x |
| 2023 | $1.41 Billion | $1.15 Billion | $328.58 Million | 1.23x | 4.30x |
| 2024 | $933.62 Million | $1.15 Billion | $345.39 Million | 0.81x | 2.70x |
| 2025 | $813.86 Million | $1.04 Billion | $186.09 Million | 0.78x | 4.37x |
Competitor Companies of 688389 by Market Capitalization
Companies near Shenzhen Lifotronic Technology Co in the global market cap rankings as of November 8, 2026. Also see 688389 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Shenzhen Lifotronic Technology Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Shenzhen Lifotronic Technology Co (2019–2026)
Market capitalization of Shenzhen Lifotronic Technology Co from 2019 to today. Between 2019 and today, Shenzhen Lifotronic Technology Co's market cap moved from $995.99 Million to $ 731.09 Million, with a yearly change of -6.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥731.09 Million | -10.17% |
| 2025 | CN¥813.86 Million | -12.83% |
| 2024 | CN¥933.62 Million | -33.85% |
| 2023 | CN¥1.41 Billion | +27.49% |
| 2022 | CN¥1.11 Billion | -21.57% |
| 2021 | CN¥1.41 Billion | +10.33% |
| 2020 | CN¥1.28 Billion | +28.46% |
| 2019 | CN¥995.99 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Shenzhen Lifotronic Technology Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $731.09 Million USD |
| MoneyControl | $731.09 Million USD |
| MarketWatch | $731.09 Million USD |
| marketcap.company | $731.09 Million USD |
| Reuters | $731.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blo… Read more